CDMOs in Asia

Acebright Group (Shanghai Acebright Pharmaceuticals) is a Chinese pharmaceutical company providing CDMO services through NMPA, FDA, EMA, and WHO-approved sites. They specialize in API manufacturing with over 20 years of technology development, and have a joint venture with Cipla for respiratory products in China.

Aurisco Pharmaceutical Co., Ltd. is a CRDMO (contract research, development and manufacturing organization) headquartered in Taizhou, Zhejiang, China, specializing in generic and complex APIs and finished dosage forms. The company focuses on small-molecule drugs, peptide therapeutics, and oligonucleotide pharmaceuticals. Aurisco operates 4 manufacturing sites and 5 R&D centers in China with 1,500+ staff, has passed 5 cGMP inspections in 2023 (USFDA, EUGMP, PMDA, NMPA, KFDA), and is expanding peptide manufacturing capacity. Their steroid product portfolio includes abiraterone acetate and complex hormone formulations.

Axcelead Drug Discovery Partners (DDP)

Japan

Axcelead Drug Discovery Partners (DDP) is a Japan-based contract research organization formed in 2017 as a Takeda spin-out, specializing in preclinical drug discovery and development. Their end-to-end platform covers target identification/validation, hit identification, lead generation/optimization, and candidate selection through IND-enabling studies. Axcelead focuses on small molecules, targeted protein degraders (TPDs), RNA-targeted small molecules, oligonucleotides, and peptides across oncology, immunology, and neuroscience therapeutic areas. The company leverages high-throughput screening, omics technologies, bioinformatics, and chemistry capabilities. They are a pure discovery/preclinical CRO and do not manufacture drug products.

AZIDUS LABORATORIES LIMITED

India

Azidus Laboratories Limited is a full-service clinical research organization (CRO) based in Chennai, India, supporting the pharmaceutical and biotechnology industries. Their services include bioavailability/bioequivalence (BA/BE) studies, Phase I-IV clinical trials management, regulatory submissions (CTD preparation), bioanalytical services (LC-MS/MS), clinical data management, statistical analysis, pharmacovigilance, and medical writing. They maintain a volunteer pool of over 45,000 participants. Azidus adheres to GCP, GLP, and international regulatory standards across therapeutic areas including oncology, cardiology, nephrology, urology, and diabetology. They are a CRO, not a drug manufacturer.

Berko Pharmaceuticals is a Turkish pharmaceutical company involved in the development, manufacturing, and marketing of pharmaceutical products including solid dosage forms and suppositories. Listed on CPHI as a CDMO specializing in development and manufacturing, with FDA-registered facilities and a long track record of FDA-inspected production (2 NAI inspections). Also has 27 FDA recalls on record, indicating substantial US market supply history.

Celanese

China

Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. In the pharmaceutical space, Celanese supplies medical-grade polymers and excipients for pharmaceutical formulations and medical devices, including its VitalDose drug delivery platform for controlled release. The company is a raw material and excipient supplier to the pharma industry, not a contract drug manufacturer.

CHA Biotech is a South Korean biotechnology company within the CHA Hospital Group, established in 2002 with over 20 years of expertise in stem cell research and cell and gene therapy. The company operates a global CGT CDMO network through its US subsidiary Matica BioLabs, with GMP facilities in Korea (CHA Bundang Medical Center, Pangyo Techno Valley) and the US (Texas). CHA Biotech offers viral vector production (500L capacity for clinical trials) and has secured multiple CDMO contracts for CAR-T and organoid therapies.

Chemport Inc. is a South Korean pharmaceutical company founded in 2008 that manufactures APIs, particularly EPA ethyl ester (Icosapent Ethyl) used in cardiovascular drugs like Vascepa. The company holds US cGMP and Korean GMP certifications for API manufacturing, with FDA registration and a clean inspection record of 3 NAI outcomes.

Chitose Bio Evolution

Japan

Chitose Bio Evolution Pte. Ltd. is a biotechnology company based in Japan and Singapore focused on zero-carbon emission through photoautotrophic microalgae production. The company works on carbon capture technology and bio-based materials rather than pharmaceutical manufacturing.

Chongqing Carelife Pharmaceutical Co., Ltd. (Kailin Pharmaceutical) is a Chinese pharmaceutical company offering CDMO services for API manufacturing. The company has 2 FDA-registered facilities with 10 FDA inspections on record, producing APIs including clindamycin and amenamevir for domestic and international markets.

Chongqing Huapont Shengchem Pharmaceutical Co., Ltd., founded in 1994, is a subsidiary of listed company Huapont Life Sciences. The company provides integrated R&D, production, and CDMO services for APIs and intermediates with 30+ years of experience, 700m3 reaction volume, 100+ R&D products, and registrations across US, EU, Japan, Korea, and China.

Chongqing Sintaho Pharmaceutical Co., Ltd. is a CDMO with 1 FDA-registered factory and 2 R&D centers, specializing in high-potency small molecules and XDC (antibody-drug conjugate linker-payloads). The company provides drug substance CDMO/CRO services with expertise in API and XDC development showcased at major industry events.

Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd

China

Chongqing Zhengchuan Pharmaceutical Packaging Co., Ltd. is a Chinese manufacturer of pharmaceutical packaging materials including glass vials, ampoules, aluminum-plastic combination covers, and antibiotic bottle caps. The company supplies packaging components to pharmaceutical manufacturers but does not manufacture drugs.

Coway International TechTrans Co., Ltd.

China

Coway International TechTrans Co., Ltd. is a China-based company that supplies pharmaceutical and nutraceutical ingredients including Vitamin K2 MK, 2'-Fucosyllactose, liposomal products (DuraLipo), natural extracts, and cosmeceutical ingredients. The company exhibits at CPHI events and appears to be an ingredient/raw material supplier rather than a contract drug manufacturer.

D. H. Organics

India

D.H. Organics is an Indian manufacturer and exporter of veterinary APIs and pharmaceutical intermediates with over 40 years of experience. Their product range includes Rafoxanide, Closantel, Closantel Sodium, Nitroxynil, and pharmaceutical intermediates such as 3,5-Diiodosalicylic Acid. They operate an FDA-approved manufacturing facility and supply to more than 30 countries.

DNS Fine Chemicals & Lab. Pvt. Ltd.

India

DNS Fine Chemicals is an Indian manufacturer and supplier of specialty chemicals, Active Pharmaceutical Ingredients, pharmaceutical intermediates, and food processing chemicals. Based in Mumbai with an FDA-certified, ISO 9001, GMP, Kosher, Halal, and FAMI-QS certified facility, they produce chemicals including sodium metaperiodate, periodic acid, and products for pharmaceutical, animal feed, food processing, and personal care industries.

EOS Med Chem Co., Ltd.

China

EOS Med Chem is a Shandong-based Chinese CMO company specializing in GMP custom synthesis of pharmaceutical intermediates and APIs, with more than 100 scientists. The company operates a 75,000 m2 GMP production facility in Shanghe and has passed site audits from major pharma companies including Teva, Hikma, Lonza, Cipla, and Sun Pharma.

Eskay Iodine Pvt Ltd

India

Eskay Iodine Pvt Ltd is an Indian API manufacturer registered with the FDA (FEI 3010331979) for API manufacturing. The company is part of the S Kant Healthcare group and has received clean FDA inspection results with 2 NAI outcomes.

FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd.

China

FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd. is a Chinese pharmaceutical company based in Nanjing that manufactures and distributes pharmaceutical intermediates, APIs, finished drugs, medical devices, and veterinary products. The company operates GMP-certified manufacturing sites and serves as a trade service and pharmaceutical supply partner to over 2,000 companies globally.

Farmson Analgesics

India

Farmson is the global leader in API Paracetamol production, established in 1969 in India. The company is backward-integrated for PAP manufacturing through hydrogenation and forward-integrated for direct compression (DC) Paracetamol, holding 22% global and 50% domestic market share.

Flamma Group

China

Flamma Group is a privately held, family-owned small molecule CDMO with experience since 1950, offering cGMP manufacturing of APIs, new chemical entities (NCEs), registered starting materials (RSMs), and pharmaceutical intermediates. The company operates FDA-inspected facilities in Italy, a GMP site in the USA (Philadelphia area), and a GMP facility in Dalian, China, providing services from early-stage development to commercial-scale manufacturing.

Fuji Chemical Industries Co., Ltd. is a Japanese pharmaceutical company specializing in API synthesis, spray drying contract manufacturing, drug product manufacturing, and excipient production. Founded in 1946 in Toyama, the company has been an FDA-inspected API manufacturer since 1981, and holds proprietary spray drying technology as well as excipient brands including Neusilin, Fujicalin, and F-melt.

FUJIFILM Irvine Scientific

Japan

FUJIFILM Irvine Scientific (now rebranded as FUJIFILM Biosciences) is a manufacturer of cell culture media and bioprocessing reagents for the life sciences and diagnostics industries. The company supplies custom and catalog cell culture media to biomanufacturers but does not itself manufacture drugs or biologics under contract.

Fuxin Custchem Fine Chemical Co., Ltd.

China

Fuxin Custchem Fine Chemical Co., Ltd. is a Chinese manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), established in 2004. The company is located in Yimatu Fluorine Chemical Industry Park in Liaoning Province, covering 67,000 square meters with a GMP workshop and 400 reactors. Products include pyridine, pyrimidine, and benzene ring series intermediates with an annual production capacity of 600 tons.

Genezen Labs (India) is the Indian entity of Genezen, a cell and gene therapy CDMO specializing in viral vector manufacturing services. The company provides lentiviral, retroviral, and adeno-associated viral (AAV) vector CDMO services, along with cell therapy manufacturing and plasmid design. Genezen operates a 60,000 sq ft cGMP facility in Fishers, Indiana and an 86,000 sq ft licensed viral vector manufacturing facility in Lexington, Massachusetts.

Gennex Laboratories Limited

India

Gennex Laboratories Limited is an Indian Active Pharmaceutical Ingredient (API) manufacturing company established in 1995, located in IDA Bollaram, Hyderabad. The company is a vertically integrated pharmaceutical manufacturer with a product portfolio spanning expectorants, muscle relaxants, analgesics, and antifungals. Gennex holds FDA registration and has been inspected by the FDA with NAI/VAI outcomes.

GTZ (India) Pvt Ltd

India

GTZ (India) Pvt Ltd is an Indian industrial chemicals company founded in 1936 that has expanded into API manufacturing, specializing in injectable iron APIs and oral iron APIs. While the bulk of its business is industrial chemicals (metal finishing, textile, leather, coating chemicals), its pharmaceutical arm manufactures and supplies active pharmaceutical ingredients meeting international standards.

Guobang Pharmaceutical Group is a global pharmaceutical manufacturing company based in Zhejiang, China, and is among China's top 100 pharmaceutical enterprises. The company specializes in APIs, key pharmaceutical intermediates, and formulations for both human and veterinary health, with products sold to over 115 countries and regions. Founded in 1996, the company employs over 4,000 people across 2,500+ acres of operational land.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. (HNSP) is a publicly-traded Chinese pharmaceutical company founded in 2000, engaged in R&D, manufacturing, and sales of pharmaceutical products with a focus on peptide APIs and injectable formulations. The company offers CDMO/contract manufacturing services representing 20-35% of revenue, and has FDA-registered facilities with multiple FDA inspection history. It operates manufacturing sites in Haikou and has invested in a Ningbo facility.

Hainan Zhonghe Pharmaceutical Co., Ltd., a subsidiary of Hainan Zhonghe (Group) Co., Ltd., is described as a leading high-tech pharmaceutical enterprise in Asia. The company manufactures pharmaceutical products including APIs and finished dosage forms such as Eptifibatide Injection, Entecavir Dispersible Tablets and Capsules, and Octreotide. It sells APIs and formulations through CPHI and other channels.

Halewood Laboratories Pvt. Ltd., established in 1984 in Ahmedabad, India, is a WHO GMP-certified contract manufacturing company specializing in pharmaceutical and food product manufacturing under loan license, third-party license, and private label arrangements. The company manufactures tablets, capsules, ORS products, effervescent tablets, energy drinks, and veterinary products, with exports to over 40 countries.

Hangzhou FST Pharmaceutical Co., Ltd., established in 2001, is a Chinese national high-tech enterprise primarily engaged in the R&D and production of APIs and pharmaceutical intermediates. The company focuses on antitumor (tinib series), cardiovascular, antihistamine, antipsychotic, and antiviral product lines, selling to South Korea, the Middle East, Europe, the United States and other regions.

Huayi Pharmaceutical (Anhui) Co., Ltd. is an EU cGMP-approved Sino-British joint venture CDMO located in Hefei, Eastern China. The company specializes in contract development and manufacturing of high-quality generic pharmaceuticals across various dosage forms, offering integrated services from API production through finished dosage form manufacturing.

Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Jingmen City, manufacturing active pharmaceutical ingredients including fludarabine phosphate, ibuprofen, and other APIs. The company is FDA-registered and has undergone multiple FDA inspections. It also offers contract manufacturing services.

Hubei Yitai Pharmaceutical Co., Ltd. is a specialized manufacturer of chemical APIs and food additives based in Hubei, China. The company is listed among top CMOs for small molecule API manufacturing with containment capabilities and participates in major pharma exhibitions such as CPhI China.

iBody Inc.

Japan

iBody Inc. is a Japanese CRO specializing in rapid monoclonal antibody discovery and generation services using its proprietary Ecobody technology. The company generates rabbit and human monoclonal antibodies for therapeutic, reagent, and diagnostic applications, including difficult-to-generate antibodies targeting low-molecular-weight compounds and post-translational modifications.

India Phosphate

India

India Phosphate is an Indian company established in 2007 that manufactures and supplies pharmaceutical raw materials used in the manufacturing process of pharmaceutical products. Their product range includes silver sulphadiazine, calcium phosphates, and povidone iodine, serving pharmaceutical, chemical, and nutraceutical industries.

I Peace Inc. is a Palo Alto, California-based biotech CDMO specializing in cGMP manufacturing of iPSC (induced pluripotent stem cells) and iPSC-derived cell products for cell and gene therapy development. The company provides custom GMP cell manufacturing, process development, cell banking (MCB/WCB), gene editing, differentiation services, and regulatory support compliant with FDA, PMDA, and EudraLex standards. I Peace has manufactured 100+ GMP iPS cell lines and tripled its CDMO facility capacity.

Jubilant Biosys Limited

India

Jubilant Biosys is a CRDMO (Contract Research, Development and Manufacturing Organization) under Jubilant Pharmova. Over 20 years experience, 2,400+ employees, five sites across India and Europe. Offers integrated drug discovery (IDD), chemistry services, biology services, and CDMO services including process R&D, analytical development, technology transfer, GLP/non-GMP/GMP manufacturing. Recently expanding into biologics and ADC discovery at European site. FDA registered with 3 FEI numbers, 14 inspections including 4 OAI -- regulatory risk flag. Note: Website claims biologics/ADC capability but this is at discovery stage only, not GMP manufacturing.

Kaisha Lifesciences Pvt. Ltd

India

Kaisha Lifesciences is a pharmaceutical company under the Dadachanji Group of Companies (30+ year heritage), offering contract R&D services from product development to scale-up, plus its own product portfolio. Part of a diversified group including Schott Kaisha (glass vials, 50% acquired by Serum Institute of India), Kaisha Packaging, and Kaisha Medisurge. WHO-GMP certified manufacturing facility for terminally sterilized and aseptically filled injectables in ampoules, vials (liquid and lyophilized), and pre-filled syringes. Departments include formulation development, analytical development, quality assurance, and regulatory affairs. Products include Enoxaparin Sodium Injection. First Indian patent approval 2021.

KareBay Biochem

China

KareBay Biochem (Monmouth Junction, NJ) is a custom synthesis and contract manufacturing company offering organic synthesis, peptide synthesis (including cGMP peptide synthesis), antibody production, protein expression, bioconjugation, oligonucleotide synthesis, RNA synthesis, polymer synthesis, and immunoassay services. Also sells catalog products (small molecule inhibitors, bioactive compounds, peptides, antibodies, amino acids, fluorescent dyes). Products are for research, laboratory and further evaluation purposes. cGMP peptide and organic synthesis services are explicitly offered.

Kevision Systems

India

Kevision Systems is an Indian company specializing in pharmaceutical track & trace, serialization, and inspection systems. Their products include the Panorama 360 inspection system, online print & inspect systems for cartons and labels/bottles, and KevSecure pharma cloud platform for serialization compliance. They serve the pharmaceutical industry as a technology/equipment vendor, not as a drug manufacturer.

Kuhnil Pharm Co., Ltd. is a South Korean pharmaceutical company headquartered in Seoul with manufacturing facilities in Cheonan. They are a prescription drug-oriented, fully-integrated pharmaceutical company that also provides CMO (contract manufacturing) services, specialized in penicillin and injection formulations. Their facilities include production lines for solid oral doses (tablets, film-coated tablets, capsules, powders), soft gelatin capsules, inhalation products, and sterile injectables (freeze-dried, liquid vials, ampoules). They achieved EU GMP approval in 2022 and have established global GMP systems with LIMS, WMS, and RWS systems.

Lake Chemicals Pvt Ltd

India

Lake Chemicals Pvt Ltd is an Indian pharmaceutical company based in Bangalore, Karnataka, specializing in the manufacture of Active Pharmaceutical Ingredients (APIs). Operating from an EU GMP-certified facility, the company focuses on pharmaceutical manufacturing and API development with a commitment to greener processes and safety standards. They provide DMF documentation support for regulatory registration and serve global markets. Listed on CPHI Online and PharmaCompass as an API manufacturer.

Laxai

India

LAXAI Life Sciences is an Indian small molecule CRDMO (Contract Research, Development and Manufacturing Organization) headquartered in Hyderabad. Offers end-to-end services spanning discovery (medicinal chemistry, synthetic chemistry, in-vitro/in-vivo biology, DMPK, safety assessment), development (chemical process development, drug product development, analytical development including method development and validation, impurity profiling, forced degradation studies), and manufacturing (preclinical to FIH supplies, late-phase and commercial, tech transfer, process validation, API manufacturing). Also manufactures specialty chemicals. Recently received investment from SIGNET Healthcare Partners. Passed USFDA audit in March 2025 with zero 483 observations.

LOTTE BIOLOGICS

South Korea

LOTTE BIOLOGICS is a global biologics CDMO headquartered in South Korea, offering end-to-end development and cGMP manufacturing services for biological Drug Substance. Operates the Syracuse Bio Campus (New York, USA) with 40,000L capacity and the Songdo Bio Campus (Incheon, South Korea) planned for 120,000L by 2027. Also operates a $100M ADC manufacturing facility.

MabPlex International

China

MabPlex International is a China-headquartered CDMO providing comprehensive biomanufacturing services for the global biopharmaceutical and biotechnology industry. They offer innovative CRO and CMO services for biologics, with facilities in China and the USA (MabPlex USA). They are expanding CDMO services and manufacturing capacity to meet global biologics demand, with multiple manufacturing sites.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.